Dosidal · Switzerland

Sandostatin LAR, Fertigspritze/Injektionspräparat

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:53161 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 53161
atc: H01CB02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1995-08-29
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: H01CB02
authorisation_number: 53161
form: PULMR
holder: Novartis Pharma Schweiz AG
holder_partner_nr: 1006575
it_number: 07.16.2.
name: Sandostatin LAR, Fertigspritze/Injektionspräparat
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
uqxIgYv9MyGhW2tqwJF6dgCZkyRX7i9etBK3QDFN-EmmXlqFJRIh7QocDfmGS6uA8zaMjFb1O674V9wy-4MgrQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:53161 · Related records in other markets · Dosidal